To see only press releases which have been disclosed pursuant to legislation or other regulations, please select “Regulatory releases” below.
Dr. Göran Ando is proposed for election to Initiator Pharma’s Board of Directors and appointed as senior advisor in business development
Initiator Pharma A/S, a clinical-stage pharma company developing innovative drugs targeting unmet medical needs within the central and peripheral nervous system, today announced that Dr. Göran Ando, former Chairman of Novo Nordisk A/S, is proposed for election to the company’s Board of Directors at the 2025 AGM. Dr. Ando is also appointed as an advisor supporting the Board and management team, effective immediately.
Dr. Göran Ando föreslås som nyval till Initiator Pharmas styrelse och utses till senior rådgivare inom affärsutveckling
Initiator Pharma A/S, ett läkemedelsbolag i klinisk fas som utvecklar innovativa läkemedel inriktade mot medicinska behov inom centrala och perifera nervsystemet, meddelade idag att Dr. Göran Ando, tidigare styrelseordförande i Novo Nordisk A/S, föreslås för inval i bolagets styrelse vid årsstämman 2025. Dr. Ando utses också som senior rådgivare till styrelsen och ledningsgruppen, med omedelbar verkan.